Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Schizophrenia

  Free Subscription


14.04.2025

1 Biol Psychiatry
1 Br J Psychiatry
1 Brain Res
2 J Clin Psychiatry
2 J Clin Psychopharmacol
1 Mol Psychiatry
5 Psychiatry Res
3 Psychol Med
11 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biol Psychiatry

  1. VYAZOVSKIY VV, Bannerman DM
    Preclinical models for schizophrenia and sleep oscillations: from biomarkers to mechanisms.
    Biol Psychiatry. 2025 Apr 8:S0006-3223(25)01115.
    PubMed        


    Br J Psychiatry

  2. LYMAN M, Fanshawe JB, Brewin J, Fanshawe TR, et al
    Introduction of point-of-care blood testing in early intervention in psychosis services: effects on physical health screening.
    Br J Psychiatry. 2025 Apr 11:1-6. doi: 10.1192/bjp.2025.
    PubMed         Abstract available


    Brain Res

  3. CHEN P, Hu H, Wang M, Li R, et al
    Modulating excitation of the mediodorsal thalamus rescues dysfunction after administration of MK-801 in rats.
    Brain Res. 2025;1855:149532.
    PubMed         Abstract available


    J Clin Psychiatry

  4. TSAI SJ, Cheng CM, Chang WH, Bai YM, et al
    Effects of Parental Severe Mental Disorders on All-Cause and Suicide Mortalities in Adolescents and Young Adults With Major Depressive Disorder.
    J Clin Psychiatry. 2025;86:24m15476.
    PubMed         Abstract available

  5. YEUNG PP, Breier A, Zhu H, Kaul I, et al
    Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia: PANSS-Excited Component Results From 3 Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials.
    J Clin Psychiatry. 2025;86:24m15668.
    PubMed         Abstract available


    J Clin Psychopharmacol

  6. FLANAGAN RJ, Obee SJ, Kim AHM, Every-Palmer S, et al
    Plasma Clozapine in Treatment Refractory Schizophrenia: What Is the Target Range?
    J Clin Psychopharmacol. 2025 Apr 9. doi: 10.1097/JCP.0000000000002007.
    PubMed         Abstract available

  7. KIKUCHI Y, Sakata M, Ikawa K, Kume D, et al
    Weekly Changes in the Clozapine Concentration-to-Dose Ratio During Clozapine Titration in Japanese Patients With Schizophrenia.
    J Clin Psychopharmacol. 2025 Apr 7. doi: 10.1097/JCP.0000000000002003.
    PubMed         Abstract available


    Mol Psychiatry

  8. HATZIPANAYIOTI A, Walther S, Gangl N, Conring F, et al
    Aberrant personal space is associated with paranoia, altered stress regulation, and unfavourable outcomes at 6 months' follow-up in schizophrenia.
    Mol Psychiatry. 2025 Apr 9. doi: 10.1038/s41380-025-02999.
    PubMed         Abstract available


    Psychiatry Res

  9. SHAKER NM, Aly El-Gabry D, Abdel Aziz K, Hashem R, et al
    Clinical and neuroradiological differences in obsessive compulsive disorder with and without psychosis.
    Psychiatry Res. 2025;348:116472.
    PubMed         Abstract available

  10. CAO C, Liu W, Hou C, Chen Y, et al
    Disrupted default mode network connectivity and its role in negative symptoms of schizophrenia.
    Psychiatry Res. 2025;348:116489.
    PubMed         Abstract available

  11. LU J, Gou N, Zhang S, Zhou J, et al
    Dysfunctional striatal-temporal connectivity is associated with a higher risk for violence in patients with schizophrenia.
    Psychiatry Res. 2025;348:116488.
    PubMed         Abstract available

  12. SIMGE UO, Burcu V, Aybuke K, Ezgi C, et al
    Clinical high risk for psychosis in bipolar disorder: Clinical features, cognition and functioning.
    Psychiatry Res. 2025;348:116478.
    PubMed         Abstract available

  13. BAILEY A, Bauer BW, Mittal VA, Ellman LM, et al
    Interpersonal difficulties and suicidal ideation in young people at clinical high-risk for psychosis and help-seeking clinical controls.
    Psychiatry Res. 2025;348:116467.
    PubMed         Abstract available


    Psychol Med

  14. CHEN YHE, Wong SMY, So MM, Suen YN, et al
    Spurious autobiographical memories of psychosis: a dopamine-gated neuroplasticity account for relapse and treatment-resistant psychosis.
    Psychol Med. 2025;55:e14.
    PubMed         Abstract available

  15. RAMI FZ, Seo H, Kang C, Park S, et al
    Associations of polygenic risk score, environmental factors, and their interactions with the risk of schizophrenia spectrum disorders.
    Psychol Med. 2025;55:e111.
    PubMed         Abstract available

  16. STRAKELJAHN F, Lincoln TM, Schlier B
    Predicting experiences of paranoia and auditory verbal hallucinations in daily life with ambulatory sensor data - A feasibility study.
    Psychol Med. 2025;55:e114.
    PubMed         Abstract available


    Schizophr Res

  17. LIU M, Tian S, Liu X, Zhang H, et al
    Analysis of differentially expressed genes in schizophrenia based on bioinformatics and corresponding mRNA expression levels.
    Schizophr Res. 2025;280:22-29.
    PubMed         Abstract available

  18. PATEL PK, Thies MB, Moyett A, Arkin S, et al
    Avolition predicts variability in optimal risk-taking in early psychosis.
    Schizophr Res. 2025;280:15-21.
    PubMed         Abstract available

  19. FORTIER A, Tikasz A, Athanassiou M, Zouaoui I, et al
    Hippocampus subfield volume reductions in treatment-resistant schizophrenia.
    Schizophr Res. 2025;280:10-14.
    PubMed        

  20. MATHIS WS, Gibbs-Dean T, Cahill JD, Srihari VH, et al
    HONE: A learning health system platform for advancing early intervention in first episode psychosis.
    Schizophr Res. 2025;280:1-9.
    PubMed         Abstract available

  21. GREVE AN, Hemager N, Piche G, Burton BK, et al
    Perceived social support in parents with schizophrenia or bipolar disorder and their co-parents: The Danish high risk and resilience study VIA 7.
    Schizophr Res. 2025;279:137-143.
    PubMed         Abstract available

  22. RETHA S, Hilmar L, Lebogang P, Sanja K, et al
    Corrigendum to "Psychopathology trajectories and relapse in first episode schizophrenia with assured long-acting injectable adherence over 24 months" [Schizophr. Res. volume 276 (2025), 8-14/article number].
    Schizophr Res. 2025 Apr 5:S0920-9964(25)00125.
    PubMed        

  23. PALOMINOS C, Kirdun M, Nikzad AH, Spilka MJ, et al
    A single composite index of semantic behavior tracks symptoms of psychosis over time.
    Schizophr Res. 2025;279:116-127.
    PubMed         Abstract available

  24. LIU K, Chen HW, Wang SA, Zhang CY, et al
    Association between serum bilirubin and type 2 diabetes mellitus risk: Findings from a schizophrenia cohort.
    Schizophr Res. 2025;279:106-115.
    PubMed         Abstract available

  25. CHEN L, Wang Z, Wang Y, Jiang H, et al
    Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective.
    Schizophr Res. 2025;279:94-105.
    PubMed         Abstract available

  26. NIELSEN JRW, Dietz M, Jefsen OH
    Blink rates in patients with schizophrenia compared to healthy controls: A meta-analysis.
    Schizophr Res. 2025;279:87-93.
    PubMed         Abstract available

  27. YUAN Q, Chen Y, Xu Y, Dimitrov LV, et al
    Cluster profiles of distressing psychotic-like experiences among children and associations with genetic risk, prenatal cannabis exposure, and social-environmental characteristics.
    Schizophr Res. 2025;278:119-127.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.